V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 270009700 | 270005731 | 1.76 | 63.6 | Palliative (P) | 2018-11-24 | 2018-12-06 | Cetuximab + FOLFIRI cycle 2 onwards | N | N | 270020209 | CETUXIMAB + IRINOTECAN + MDG |
| 270009701 | 270005732 | 1.64 | 78.3 | Curative (C) | 2014-04-18 | 2014-04-18 | CARBOPLATIN + PACLITAXEL | 02 | N | 270020213 | CAPECITABINE + CARBOPLATIN |
| 270009702 | 270005733 | 1.77 | 64.5 | Neo-adjuvant (N) | 2015-11-07 | 2015-11-08 | Cetuximab +Cisplatin + FU (Cycle 1) | 02 | N | 270020223 | CETUXIMAB |
| 270009703 | 270005733 | 1.79 | 71 | Palliative (P) | 2014-06-27 | 2014-07-10 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | 270020223 | CARBOPLATIN + ETOPOSIDE |
| 270009704 | 270005733 | 1.55 | 61.4 | Palliative (P) | 2013-06-19 | 2013-07-17 | Irinotecan | 01 | N | 270020223 | CAPECITABINE + IRINOTECAN |
| 270009705 | 270005734 | 1.73 | 73 | Curative (C) | 2014-08-06 | 2014-08-21 | CARBOPLATIN + RT | N | N | 270020246 | CETUXIMAB |
| 270009706 | 270005735 | 1.82 | 90.3 | Curative (C) | 2014-01-07 | 2014-01-28 | Cetuximab + Radiotherapy Load | 02 | Y | 270020254 | SCOT TRIAL |
| 270009707 | 270005736 | 1.75 | 78.8 | Curative (C) | 2017-10-24 | 2017-10-25 | Cetuximab + FOLFIRI cycle 2 onwards | N | N | 270020256 | CETUXIMAB + RT |
| 270009708 | 270005737 | 1.64 | 95.2 | Palliative (P) | 2015-11-09 | 2015-11-10 | CARBOPLATIN + RT | 02 | N | 270020271 | CETUXIMAB |
| 270009709 | 270012828 | 1.59 | 89.8 | Curative (C) | 2017-10-31 | 2017-10-31 | Cetuximab + Radiotherapy Load | N | N | 270020286 | CARBOPLATIN |
| 270009710 | 270005738 | null | null | Palliative (P) | 2015-02-14 | 2015-02-14 | CETUXIMAB + IRINOTECAN + MDG | N | N | 270020297 | IRINOTECAN + MDG + PANITUMUMAB |
| 270009711 | 270005739 | 1.64 | 63 | Palliative (P) | 2013-10-01 | 2013-10-01 | Carboplatin AUC 6 - 10 | N | N | 270020323 | TRASTUZUMAB |
| 270009712 | 270005739 | 1.7 | 75.4 | Palliative (P) | 2018-01-16 | 2018-01-16 | CETUXIMAB + IRINOTECAN + MDG | 2 | N | 270020323 | IRINOTECAN + MDG + PANITUMUMAB |
| 270009713 | 270016031 | 1.77 | 72 | null | 2014-01-04 | 2014-01-12 | Cetuximab +Cisplatin + FU (Cycle 1) | N | N | 270020340 | CARBOPLATIN + RT |
| 270009714 | 270005740 | 1.66 | 90.3 | Curative (C) | 2016-03-03 | 2016-03-11 | CARBOPLATIN + RT | N | N | 270020347 | CETUXIMAB |
| 270009715 | 270005741 | 1.74 | 99 | Adjuvant (A) | 2017-07-06 | 2017-07-19 | Cetuximab + Radiotherapy Load | N | N | 270020354 | FLUOROURACIL + RT |
| 270009716 | 270012830 | 1.75 | 92.2 | Palliative (P) | 2018-06-21 | 2018-06-21 | CARBOPLATIN + PACLITAXEL + RT | 02 | N | 270020355 | CISPLATIN + FLUOROURACIL + RT |
| 270009717 | 270005742 | 1.66 | 80 | null | 2015-09-04 | 2015-09-05 | Bevacizumab + Cape + Oxali 14day | null | Y | 270020360 | CETUXIMAB |
| 270009718 | 270005742 | 0 | 61 | Palliative (P) | 2014-01-18 | 2014-01-19 | Cetuximab + FOLFIRI cycle1 | 02 | N | 270020360 | CARBOPLATIN + PEMETREXED |
| 270009719 | 270005743 | 1.68 | 93.7 | Curative (C) | null | 2014-02-04 | CETUXIMAB + IRINOTECAN + MDG | null | null | 270020391 | BEVACIZUMAB + OXALIPLATIN + MdG |
| 270009720 | 270005744 | 1.51 | 59.6 | Palliative (P) | 2019-01-30 | 2019-02-25 | CISPLATIN + VINORELBINE + RT | N | Y | 270020395 | CETUXIMAB + IRINOTECAN + MDG |
| 270009721 | 270005745 | 1.6 | 60.2 | Neo-adjuvant (N) | 2015-11-11 | 2015-11-13 | CETUXIMAB + RT | 2 | Y | 270020403 | ABIRATERONE |
| 270009722 | 270005746 | 1.65 | 106 | Palliative (P) | 2013-12-21 | 2013-12-29 | Capecitabine (21 day) + Irinotecan | 2 | N | 270020405 | BEVACIZUMAB + CAPE + OXALIPLATIN |
| 270009723 | 270005747 | 1.71 | 77.7 | Palliative (P) | 2013-03-04 | 2013-03-04 | Cetuximab 14 day | N | N | 270020411 | IRINOTECAN + MDG + PANITUMUMAB |
| 270009724 | 270005748 | null | 84.2 | Adjuvant (A) | 2014-09-05 | 2014-09-22 | CARBOPLATIN + RT | N | N | 270020424 | CETUXIMAB + RT |
| 270009725 | 270012832 | 1.62 | 51 | Curative (C) | 2015-09-05 | 2017-02-13 | Cetuximab + Radiotherapy Load | Y | N | 270020425 | CARBOPLATIN |
| 270009726 | 270012832 | null | 75 | Curative (C) | 2015-02-02 | 2015-02-04 | Cetuximab + Radiotherapy Load | 02 | N | 270020425 | CETUXIMAB + RT |
| 270009727 | 270017850 | 1.7 | 108 | Curative (C) | 2013-12-17 | 2013-12-19 | Bevacizumab 10mg/kg | Y | N | 270020433 | CETUXIMAB + RT |
| 270009728 | 270005749 | 1.68 | 100 | Palliative (P) | 2013-01-06 | 2013-05-18 | Fluorouracil+Mitomycin+RT (Anal Ca) | 02 | N | 270020438 | FOXFIRE TRIAL |
| 270009729 | 270005749 | 1.72 | 88.6 | null | 2013-05-18 | 2013-05-24 | CARBOPLATIN | N | N | 270020438 | BEVACIZUMAB |
| 270009730 | 270005749 | 1.66 | 61.6 | Curative (C) | 2017-03-05 | 2017-03-11 | Carboplatin + Vinorelbine Oral | 2 | N | 270020438 | FLUOROURACIL + MITOMYCIN + RT |
| 270009731 | 270005750 | null | null | Adjuvant (A) | 2017-06-21 | 2017-06-21 | null | Y | N | 270020443 | CETUXIMAB |
| 270009732 | 270005751 | null | null | Curative (C) | 2013-08-27 | 2013-08-31 | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | N | null | 270020445 | CARBOPLATIN + RT |
| 270009733 | 270005752 | 1 | 69 | Palliative (P) | null | 2017-03-31 | Ifosfamide 3g/m2 5 day | null | null | 270020457 | CETUXIMAB + OXALIPLATIN + MDG |
| 270009734 | 270005753 | 1.79 | 57.75 | Palliative (P) | 2015-07-27 | 2015-08-04 | Carboplatin AUC 6 - 10 | N | N | 270020461 | ENZALUTAMIDE |
| 270009735 | 270005754 | 1.73 | 71 | Neo-adjuvant (N) | 2017-04-27 | 2017-04-28 | Capecitabine (14 day) + Irinotecan | 1 | N | 270020472 | IRINOTECAN |
| 270009736 | 270005754 | 1.68 | 69 | Not known (9) | 2017-04-02 | 2017-04-04 | Cetuximab + Radiotherapy Load | N | N | 270020472 | ENZALUTAMIDE |
| 270009737 | 270005754 | 1.75 | 88.1 | Curative (C) | 2017-01-29 | 2017-01-29 | CARBOPLATIN + FLUOROURACIL | 02 | N | 270020472 | CETUXIMAB |
| 270009738 | 270005755 | 1.52 | 51.9 | Curative (C) | 2015-02-23 | 2015-03-13 | ChIVPP/EVA | N | N | 270020484 | VINBLASTINE |
| 270009739 | 270005756 | 1.7 | 48.1 | Curative (C) | 2015-05-07 | 2015-05-15 | BENDAMUSTINE + RITUXIMAB | N | N | 270020487 | CVP R |
| 270009740 | 270005757 | 1.63 | 57.75 | Curative (C) | 2013-07-05 | 2013-07-22 | IVE | N | Y | 270020488 | CVP R |
| 270009741 | 270012835 | 1.6 | 60 | null | 2017-04-24 | 2017-04-25 | Bevacizumab + Oxaliplatin +MdG | 02 | N | 270020499 | IBRUTINIB |
| 270009742 | 270012835 | 1.75 | 63.5 | Curative (C) | 2016-10-14 | 2016-10-31 | Vinblastine | N | N | 270020499 | VINBLASTINE |
| 270009743 | 270012835 | null | 63 | null | 2014-04-03 | 2014-04-16 | R ABVD | N | N | 270020499 | ABVD R |
| 270009744 | 270005758 | null | 94.2 | Palliative (P) | 2013-11-08 | 2014-01-01 | ECHELON-1 TRIAL | N | N | 270020542 | CVP R |
| 270009745 | 270005759 | null | 0 | Curative (C) | 2014-04-21 | 2014-04-27 | CVP R | 02 | N | 270020545 | CETUXIMAB + IRINOTECAN + MDG |
| 270009746 | 270005760 | 1.75 | 78 | Curative (C) | 2018-01-11 | 2018-01-17 | CHOP - 21 days | N | N | 270020547 | CHLORAMBUCIL |
| 270009747 | 270005760 | 0 | 63 | Curative (C) | 2016-12-04 | 2016-12-18 | CYCLOPHOSPHAMIDE + GEMCITABINE + RITUXIMAB + VINCRISTINE | N | N | 270020547 | RITUXIMAB |
| 270009748 | 270005761 | 1.9 | 105 | Curative (C) | 2013-05-20 | 2013-06-05 | Hydroxycarbamide | N | N | 270020552 | BEVACIZUMAB + OXALIPLATIN + MdG |
| 270009749 | 270005761 | 1.55 | 77 | Curative (C) | 2013-02-13 | 2013-02-16 | BREVITY TRIAL | 2 | N | 270020552 | DHAP |